Policy hub

Policy

The latest stories on science and innovation policy

C&I Issue 9 2025
Read the latest issue ISSUE 9 2025
C&I Issue 7 2025
SUBSCRIBE Never miss an issue
C&I Issue 6 2025
Big chemical companies back project to turn waste into feedstocks
Policy
Big chemical companies back project to turn waste into feedstocks

A research project which is focused on the possible direct conversion of waste into chemicals via a sustainable route has been backed by a number of major chemicals companies.

 
Life science investment benefits 'undervalued' warns report
Policy
Life science investment benefits 'undervalued' warns report

An over-reliance on metrics such as benefit cost ratio to...

Scientific papers, patents and VC deals: The world's top innovation locations revealed
Science & Innovation
Scientific papers, patents and VC deals: The world's top innovation locations revealed
The Shenzhen–Hong Kong–Guangzhou region has been...
Why Europe's chemicals industry has had a 'disappointing' year so far
Energy
Why Europe's chemicals industry has had a 'disappointing' year so far
The first half of 2025 has been ‘disappointing’ ...
Sustainability & Environment
Go with the flow
C&I Premium Content
Policy
Leader: Chemical industry at the crossroads
C&I
Policy
More delays for UK REACH
C&I Premium Content
Policy
NIH Foundation pushes for end of animal testing
C&I Premium Content
Science & Innovation
Comment: Robotics in reskilling and transition
C&I Premium Content
Policy
Pharma tariff uncertainty continues
C&I Premium Content

 INSIDE THE LATEST ISSUE

C&I Issue 9 2025
C and I Icon
Show me news from
All themes
from
All categories
by
All years
search by

Read the latest news

C&I news and features

More delays for UK REACH
Policy
More delays for UK REACH
Premium Content
NIH Foundation pushes for end of animal testing
Policy
NIH Foundation pushes for end of animal testing
Premium Content
Leader: Chemical industry at the crossroads
Policy
Leader: Chemical industry at the crossroads
FDA halts new clinical trials that export Americans’ cells to China for genetic engineering
Policy
FDA halts new clinical trials that export Americans’ cells to China for genetic engineering
Premium Content